Study Suggests Bulk Adverse Event Reporting May Delay Medical Device Safety Warnings

A study published in The BMJ indicates that allowing medical device manufacturers to submit bulk summary reports of adverse events to the U.S. Food and Drug Administration (FDA), rather than individual case reports, may hinder the timely detection of potential safety signals. This raises concerns about the promptness of medical device safety warnings and patient safety.